Liquid Nitrogen and Carbon Dioxide deliveries
The Food and Drug Administration's Office of Acquisition and Grant Services seeks delivery of liquid nitrogen and carbon dioxide to support laboratory operations, with quotes due May 26, 2026, by 1:00 p.m. Central Time. This is a firm fixed-price commercial items procurement open to full and open competition.
Place of performance is Building WO-64 in Silver Spring, Maryland 20993, with FOB destination and installation included. The solicitation requires liquid nitrogen in 240-liter dewars with digital gauges and carbon dioxide in 50-lb and 20-lb cylinders at estimated frequencies ranging from every two weeks to annually. All tanks must be equipped with functional digital gauges, filled to at least 90% capacity, free from damage, and compliant with certification requirements. Delivery must occur within guaranteed one-hour windows, coordinated by phone at least two business days in advance Monday through Friday, 8:00 a.m. to 4:00 p.m. Eastern Time, excluding Federal holidays. The contractor must remove empty cylinders at delivery and ensure all connections are leak-free.
The base performance period runs June 1, 2026, through May 30, 2027, with three optional one-year renewal periods extending through May 30, 2030. Quoters must submit firm pricing through September 30, 2026, detailed technical capability information demonstrating past performance supplying industrial gases within the past three years, and country-of-origin information for Buy American Act compliance. Evaluation weighs technical capability and past performance collectively as more important than price, with price as a significant consideration. The NAICS code is 325120, Industrial Gas Manufacturing, with a small business size standard of 1,200 employees. Invoices must be submitted electronically through the Treasury Invoice Processing Platform with payment due Net 30 days after government acceptance. Submit quotes to warren.dutter@fda.hhs.gov.
75F40126Q133600 Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services
5/18/26, 10:56 AM Liquid Nitrogen and Carbon Dioxide deliveries
The Food and Drug Administration's Office of Acquisition and Grant Services, on behalf of the Center for Drug Evaluation and Research (CDER), has issued a Source Sought Notice seeking vendors capable of supplying liquid nitrogen and carbon dioxide deliveries. This is market research to identify capable suppliers rather than a formal solicitation, and no contract will be awarded directly from this announcement. The requirement encompasses delivering liquid nitrogen in 240-liter dewars, carbon dioxide in 50-pound and 20-pound cylinders, and nitrogen gas products in varying grades and sizes to the FDA facility in Silver Spring, Maryland. Vendors must demonstrate capability to coordinate deliveries by phone with at least two business days' notice for Monday through Friday delivery windows between 8:00 a.m. and 4:00 p.m. Eastern Time, with all tanks meeting requirements for functional digital gauges, minimum 90% fill capacity, and leak-free condition. Interested parties must submit responses by email to Warren.Dutter@fda.hhs.gov by May 5, 2026, at 1:00 PM Central Time, with submissions including business information, UEI number, past performance data, product literature, technical specifications, pricing information, manufacturing location details for Buy American Act compliance, and relevant GSA or government-wide contract information.
This procurement carries no small business set-aside, though it specifically targets small business concerns under NAICS Code 325120 (Industrial Gas Manufacturing) with a size standard of 1,200 employees; however, all interested parties may respond. The estimated annual delivery volumes include 26 liquid nitrogen deliveries every two weeks, 4 deliveries of 50-pound carbon dioxide cylinders every three months, and supplementary nitrogen gas deliveries on varying schedules, with all deliveries on a FOB Destination basis including shipping and installation. The performance period extends from June 1, 2026, through May 30, 2031, comprising a base year and four option years, providing a five-year contract framework for the qualified vendor. No specific award value or budget range has been disclosed in this source sought notice, as the announcement is intended solely to identify and evaluate market capability prior to formal solicitation development.
FDA-SSN-133600 Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services
4/28/26, 11:42 AM